Pregled bibliografske jedinice broj: 999309
The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes
The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes // European heart journal, 41 (2020), 2; 325-325 doi:10.1093/eurheartj/ehz242 (međunarodna recenzija, pismo uredniku, znanstveni)
CROSBI ID: 999309 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The possible role of insulin and glucagon in
patients with heart failure and Type 2 diabetes
Autori
Skelin, Marko ; Lucijanić, Marko ; Javor, Eugen
Izvornik
European heart journal (0195-668X) 41
(2020), 2;
325-325
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, znanstveni
Ključne riječi
heart failure, diabetes mellitus, type 2, glucagon, insulin
Sažetak
Maack et al.1 described metabolic alterations and therapeutic interventions in patients with heart failure (HF) and diabetes. However, some mechanisms might have been overseen. Currently, only two antidiabetic agents (empagliflozin and liraglutide) caused a reduction in mortality, as a single-observed endpoint. Interestingly, neither of the drugs showed any effect on non- fatal myocardial infarction or stroke.2 Empagliflozin and liraglutide belong to different classes of antidiabetic agents, but share...
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Opća bolnica Šibenik,
Klinička bolnica "Dubrava"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
